The Clinical Study of CD20 CAR-T Cells in Patients With Relapsed and Refractory B Cell Non-Hodgkin Lymphoma
Clinical trial NCT04169932 · UNKNOWN
Trial details
- NCT number
- NCT04169932
- Sponsor
- Shanghai Longyao Biotechnology Inc., Ltd.
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-22
- Primary completion
- 2022-11-22
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.